Loading live market data…

Fate Therapeutics, Inc.

NASDAQ:FATE

$2.99 USD

$0 (0.0%)

Volume
1.93M
Average Volume
4.09M
Market Capitalization
$348.51M
P/E Ratio
-2.74
Dividend Yield
0.00%
Price Target
$5.50
Year High
$3.23
Year Low
$0.91
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$5.85

FATE Estimated and Actual Revenue by Quarter

FATE Estimated and Actual EPS by Quarter

FATE Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2029-12-31 5 -22.67M -22.67M -22.67M -22.67M -22.67M -22.67M
2029-09-30 4 -18.31M -18.31M -18.31M -18.31M -18.31M -18.31M
2029-06-30 4 -14.13M -14.13M -14.13M -14.13M -14.13M -14.13M
2029-03-31 5 -7.83M -7.83M -7.83M -7.83M -7.83M -7.83M
2028-12-31 2 -636.61K -636.61K -636.61K -636.61K -636.61K -636.61K
2028-09-30 2 -679.26K -679.26K -679.26K -679.26K -679.26K -679.26K
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2029-12-31 5 -43.14M -43.14M -43.14M 77.42M 77.42M 77.42M
2029-09-30 4 -42.56M -42.56M -42.56M 62.52M 62.52M 62.52M
2029-06-30 4 -42.74M -42.74M -42.74M 48.26M 48.26M 48.26M
2029-03-31 5 -45.79M -45.79M -45.79M 26.73M 26.73M 26.73M
2028-12-31 2 -45.41M -45.41M -45.41M 2.17M 2.17M 2.17M
2028-09-30 2 -40.1M -40.1M -40.1M 2.32M 2.32M 2.32M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2029-12-31 5 22.67M 22.67M 22.67M 4 -0.3594 -0.3594 -0.3594
2029-09-30 4 18.31M 18.31M 18.31M 3 -0.3546 -0.3546 -0.3546
2029-06-30 4 14.13M 14.13M 14.13M 3 -0.3561 -0.3561 -0.3561
2029-03-31 5 7.83M 7.83M 7.83M 4 -0.3815 -0.3815 -0.3815
2028-12-31 2 636.61K 636.61K 636.61K 3 -0.3783 -0.3783 -0.3783
2028-09-30 2 679.26K 679.26K 679.26K 3 -0.3341 -0.3341 -0.3341